Hyperion DeFi, Inc.

Price Chart

Risk-Adjusted Performance

Hyperion DeFi, Inc. (HYPD) Price Performance

Hyperion DeFi, Inc. (HYPD) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $3.93, down 1.26% from the previous close.

Over the past year, HYPD has traded between a low of $1.03 and a high of $15.97. The stock has gained 247.8% over this period. It is currently 75.4% below its 52-week high.

Hyperion DeFi, Inc. has a market capitalization of $28.98M.

About Hyperion DeFi, Inc.

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.